These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1976794

  • 21. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
    Carbonin PU, Greco A, Pisanti P, Gemma A, Cattelin F.
    Clin Neuropharmacol; 1990; 13 Suppl 3():S92-9. PubMed ID: 2093422
    [Abstract] [Full Text] [Related]

  • 22. Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
    Chan P.
    Eur Neurol; 1995; 35 Suppl 1():23-7. PubMed ID: 8529726
    [No Abstract] [Full Text] [Related]

  • 23. Selectivity of raubasine stereoisomers for alpha 1- and alpha 2-adrenoceptors in the rat.
    Roquebert J.
    Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):252-61. PubMed ID: 3021076
    [Abstract] [Full Text] [Related]

  • 24. Glial fibrillary acidic protein expression after transient brain ischemia: evidence for a pharmacological modulation by almitrine-raubasine.
    Pujol JF, Ginovart N, Debure L, Rousset C, Weissmann D.
    Eur Neurol; 1995 Aug; 35 Suppl 1():12-6. PubMed ID: 8529723
    [No Abstract] [Full Text] [Related]

  • 25. Dihydroergocristine and memory alterations of aged male rats.
    Drago F, Valerio C, Scalisi B, D'Agata V, Scapagnini U.
    Pharmacol Biochem Behav; 1988 Aug; 30(4):961-5. PubMed ID: 3147464
    [Abstract] [Full Text] [Related]

  • 26. Metabolic and circulatory evaluation of cerebral ischemic accident in humans by positron emission tomography: a pilot study with almitrine-raubasine.
    Depresseux JC, Franck G, Van Cauwenberge H, Cattelin F.
    Clin Neuropharmacol; 1990 Aug; 13 Suppl 3():S40-9. PubMed ID: 2093417
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of indeloxazine hydrochloride on passive avoidance behavior of senescence-accelerated mice.
    Yamamoto M, Iwai A, Kawabata S, Ozawa Y, Shimizu M.
    Eur J Pharmacol; 1989 Jul 18; 166(2):345-8. PubMed ID: 2792199
    [Abstract] [Full Text] [Related]

  • 33. [Differential inhibition of raubasine and tetrahydroalstonine on the vasopressor response to sympathetic nervous stimulation and intravenous noradrenaline in the pithed rat].
    Roquebert J, Demichel P, Dufour P.
    J Pharmacol; 1985 Jul 18; 16(4):412-20. PubMed ID: 2869187
    [Abstract] [Full Text] [Related]

  • 34. [Effects of aging and various pharmacologic agents on the brain energy metabolism in the course of post-hypoglycemic recuperation in the rat].
    Villa RF, Pastoris O.
    Presse Med; 1987 Jun 18; 16(23):1128-34. PubMed ID: 2885824
    [Abstract] [Full Text] [Related]

  • 35. Effects of VA-045, a novel apovincaminic acid derivative, on age-related impairment evidence in electroencephalograph, caudate spindle, a passive avoidance task and cerebral blood flow in rats.
    Okuyama S, Hashimoto-Kitsukawa S, Ogawa S, Imagawa Y, Kawashima K, Kawashima Y, Araki H, Otomo S.
    Gen Pharmacol; 1994 Nov 18; 25(7):1311-20. PubMed ID: 7896040
    [Abstract] [Full Text] [Related]

  • 36. [Effect of almitrine/raubasine on cerebral metabolism in the elderly].
    Allain H, Bentué-Ferrer D.
    Presse Med; 2002 Mar 30; 31(12):562-4. PubMed ID: 11984975
    [Abstract] [Full Text] [Related]

  • 37. Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
    Guez D.
    Clin Neuropharmacol; 1990 Mar 30; 13 Suppl 3():S109-16. PubMed ID: 2093415
    [Abstract] [Full Text] [Related]

  • 38. [Iskedyl and general anesthesia. Measurement of the systolic ejection volume and peripheral resistance using the arterial pressure curves].
    Laborit G, Seroussi S, Neff R.
    Ann Anesthesiol Fr; 1975 Mar 30; 16(2):69-76. PubMed ID: 5007
    [Abstract] [Full Text] [Related]

  • 39. The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.
    Foley AG, Murphy KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, Walsh FS, Regan CM.
    Neuropsychopharmacology; 2004 Jan 30; 29(1):93-100. PubMed ID: 14571256
    [Abstract] [Full Text] [Related]

  • 40. [Effect of a tissue oxygenator (almitrine + raubasine) on the metabolism of 2,3-diphosphoglycerate of rabbits submitted by hypoxia].
    Callis A, Dorance M, Magnan de Bornier B.
    C R Seances Soc Biol Fil; 1980 Jan 30; 174(6):1006-9. PubMed ID: 6451260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.